Pharmedica USA Recalls Purely Soothing Eye Drops

By RTTNews Staff Writer   ✉   | Published:

Phoenix, Arizona-based Pharmedica USA LLC is recalling two lots of Purely Soothing, 15 percent MSM eye drops to the consumer level due to non-sterility, the U.S. Food and Drug Administration said.

The eye drop is used as an anti-inflammatory aimed to assist with symptoms of ocular irritation and/or swelling.

The eye drops, packaged in white, cylindrical HDPE bottles, have eye dropper caps and white lids. They are in packages with LOT#: 2203PS01, 1 oz, UPC 7 31034 91379 9; and LOT#: 1808051, 1/2 oz, UPC 7 31034 91382 9.

The affected products were distributed worldwide by Purely Soothing LLC through online e-commerce and Trade shows, ex. Amazon Marketplace, Etc.

The agency noted that the use of contaminated eye drops can result in the risk of eye infections that could result in blindness.

However, Pharmedica USA has not received any reports of adverse events or illness related to this recalled product to date.

Pharmedica urged customers to immediately stop using the product and return it to the place of purchase.

Wholesalers and retailers are asked to stop distributing the products, and to return to the company immediately or confirm that the product has been disposed properly.

In recent recalls, Global Pharma Healthcare in late February called back certain artificial eye ointment, distributed by Delsam Pharma LLC to the consumer level, citing possible microbial contamination. Artificial Eye Ointment is used as an eye lubricant and to relieve dryness of the eyes.

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Networking systems firm Ciena Corp. (CIEN) reported on Monday that profit for the first quarter increased from last year, driven by strong 25 percent revenue growth despite supply chain challenges. Adjusted earnings per share and quarterly revenues topped analysts' expectations. Luxury electric major Tesla Inc. has slashed prices of its Model S sedan and Model X SUV vehicles in the United States, aiming to boost demand. The price cut comes for the second time this year after the company drastically cut prices in January in a bid to boost sales. According to the company's website, around $5,000 was reduced on Model S price and around $10,000 on Model X vehicles. U.S. investment manager Harris Associates, once a major shareholder of Credit Suisse Group AG, has sold its entire stake in the Swiss banking major, the Financial Times reported. The investor ended its about two decades of ownership after raising questions about the future of the franchise.